| RID | Radiation-Induced Dermatitis |
| RT | Radiotherapy |
| Gy | Gray (Unit) |
| SP | Spectrophotometry |
| CTCAE | Common Terminology Criteria for Adverse Effects |
| RTOG | Radiation Therapy Oncology Group |
| EORTG | European Organization for Research and Treatment of Cancer |
| L* max | maximum L value (spectrophotometry) |
| a* max | maximum a value (spectrophotometry) |
| b* max | maximum b value (spectrophotometry) |
| RISRAS | Radiation-Induced Skin Reaction Assessment Scale |
| fx | Fraction(s) |
| CF | Conventional Fractionation |
| HF | Hypofractionation |
| SD | Standard Deviation |
| WBI | Whole Breast Irradiation |
| BMI | Body Mass Index |
| TNM | TNM Classification of Malignant Tumors |
| DCIS | Ductal Carcinoma In Situ |
| HI(D2%–D98%)/D50% | Homogeneity Index(D2%–D98%)/D50% |
| HI-RTOG | Homogeneity Index (Radiation Therapy Oncology Group) |
| SW | Sliding Window |
| VMAT | Volumetric (partial-) arc therapy |
| IMRT | Intensity-modulated Radiotherapy (sliding-window) |
| Dmean | Mean dose within the target volume |
| rel. D2% | Dose received by 2% of the target volume relative to the prescribed dose |
| rel. D50% | Dose received by 50% of the target volume relative to the prescribed dose |
| rel. D98% | Dose received by 98% of the target volume relative to the prescribed dose |
| V≥107% | Volume receiving ≥ 107% of prescribed dose |
| ANOVA | Analysis Of Variance |